Bausch + Lomb CEO Brent Saunders exits with $75.5M separation; Thomas Appio named interim CEO

Bausch & Lomb Corp

Brent Saunders departs as CEO and board member effective Oct 12, 2026 by mutual agreement; company says exit is not due to any dispute or disagreement.
Separation Agreement: $75.5M lump-sum cash plus up to $50,000 in attorneys' fees; two years of group health plan participation; no other severance under his 2023 Employment Agreement.
All of Saunders' outstanding equity awards (options, RSUs, matching RSUs, PSUs, leveraged PSUs, New Hire Grants) were forfeited and cancelled upon signing.
Thomas J. Appio, BLCO board chairman since August 2026 and Bausch Health CEO since 2022, becomes interim CEO immediately while remaining CEO of controlling shareholder BHC.
BLCO and BHC expect to raise FY2026 adjusted EBITDA excluding Acquired IPR&D guidance on preliminary Q3 results; details at the Oct. 28, 2026 Q3 report.

item 5.02 item 7.01 item 9.01

Featured in Daily 8-K Digest

Selected #1 for 2026-10-13. Read digest

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Thomas J. Appio

interim Chief Executive Officer

BLCO · Bausch & Lomb Corp

Effective: 2026-10-12
Filed: October 13, 2026, 6:09 AM ET

Thomas J. Appio, who is currently Chairman of the Board, was appointed to serve as the interim Chief Executive Officer of the Company, effective as of October 12, 2026.

Departed

Brent Saunders

Chief Executive Officer

BLCO · Bausch & Lomb Corp

Effective: 2026-10-12
Successor: Thomas J. Appio
Filed: October 13, 2026, 6:09 AM ET

On October 12, 2026, Bausch + Lomb Corporation (the “Company”) announced that Brent Saunders, Chief Executive Officer of the Company and a member of the Company’s board of directors (the “Board”), and the Board have mutually agreed that Mr. Saunders will depart from the Company, effective as of October 12, 2026 (the “Separation Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas J. Appio was appointed as interim Chief Executive Officer at Bausch & Lomb Corp.

Action: appointed
Role: interim Chief Executive Officer

Exact text from the filing

Thomas J. Appio, who is currently Chairman of the Board, was appointed to serve as the interim Chief Executive Officer of the Company, effective as of October 12, 2026.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Brent Saunders departed as Chief Executive Officer at Bausch & Lomb Corp.

Action: depart
Role: Chief Executive Officer

Exact text from the filing

On October 12, 2026, Bausch + Lomb Corporation (the “Company”) announced that Brent Saunders, Chief Executive Officer of the Company and a member of the Company’s board of directors (the “Board”), and the Board have mutually agreed that Mr. Saunders will depart from the Company, effective as of October 12, 2026 (the “Separation Date”).

View on SEC.gov

Bausch & Lomb Corp filing history →

Source: SEC EDGAR

accession 0000950103-26-015460

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.